| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3006064 | Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health | 2014 | 4 Pages |
Abstract
SynopsisHydralazine and labetalol for intravenous use are equally effective in the management of hypertensive crisis in pregnant patients (24 weeks or more) with severe hypertensive disorders of pregnancy, showing a similar frequency of adverse effects in both groups.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Samuel Delgado De Pasquale, Rodrigo Velarde, Osvaldo Reyes, Kerima De La Ossa,